




























Publisher's PDF, also known as Version of record
Link to publication record in King's Research Portal
Citation for published version (APA):
Hu, M. H., Bashir, Z., Li, X. F., & O'Byrne, K. T. (2016). Posterodorsal Medial Amygdala Mediates Tail-Pinch
Induced Food Intake in Female Rats. Journal of Neuroendocrinology, 28(5). 10.1111/jne.12390
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 18. Feb. 2017
Journal of Neuroendocrinology, 2016, 28, 10.1111/jne.12390
ORIGINAL ARTICLE © 2016 The Authors. Journal of Neuroendocrinology published by John Wiley & Sons Ltdon behalf of British Society for Neuroendocrinology
Posterodorsal Medial Amygdala Mediates Tail-Pinch Induced Food Intake
in Female Rats
M. H. Hu, Z. Bashir, X. F. Li and K. T. O’Byrne
Division of Women’s Health, Faculty of Life Sciences and Medicine, King’s College London, London, UK.
Journal of
Neuroendocrinology
Correspondence to: Kevin O’Byrne,
Division of Women’s Health, Faculty
of Life Sciences & Medicine, 2.92W,
Hodgkin Building, King’s College
London, Guy’s Campus, London SE1
1UL, UK (e-mail: kevin.obyrne@kcl.ac.
uk).
This is an open access article under
the terms of the Creative Commons
Attribution License, which permits use,
distribution and reproduction in any
medium, provided the original work is
properly cited.
Comfort eating during periods of stress is a common phenomenon observed in both animals
and humans. However, the underlying mechanisms of stress-induced food intake remain elusive.
The amygdala plays a central role in higher-order emotional processing and the posterodorsal
subnucleus of the medial amygdala (MePD), in particular, is involved in food intake. Extra-
hypothalamic corticotrophin-releasing factor (CRF) is well recognised for mediating behavioural
responses to stress. To explore the possible role of amygdala CRF receptor activation in stress-
induced food intake, we evaluated whether a stressor such as tail-pinch, which reliably induces
food intake, would fail to do so in animals bearing bilateral neurotoxic lesions of the MePD. Our
results showed that ibotenic acid induced lesions of the MePD markedly reduced tail-pinch
induced food intake in ovariectomised, 17b-oestradiol replaced rats. In addition, intra-MePD
(right side only) administration of CRF (0.002 or 0.02 ng) via chronically implanted cannulae
resulted in a dose-dependent increase in food intake, although higher doses of 0.2 and 2 ng
CRF had less effect, producing a bell shaped curve. Furthermore, intra-MePD (bilateral) adminis-
tration of the CRF receptor antagonist, astressin (0.3 lg per side) effectively blocked tail-pinch
induced food intake. These data suggest that the MePD is involved in stress-induced food intake
and that the amygdala CRF system may be a mediator of comfort eating.
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Stress-induced feeding or ‘comfort eating’ is a commonly experi-
enced phenomenon and is characterised by an increase in food
intake when faced with emotionally or physically challenging events
(1,2). It is a likely contributor to the increased prevalence of obesity
in those suffering from stress-related conditions. Studies have
linked major depressive disorder and generalised anxiety disorder in
adolescence to an increased risk of obesity in adulthood (3). Despite
the commonality of this behaviour, the responsible mediators of
stress-induced feeding remain elusive.
Exposure to various psychological stressors, such as restraint and
footshock, inhibits feeding behaviour in rodents (1,4). By contrast,
mild stressors such as tail-pinch reliably induce food intake in rats
(1,4). The classical stress neuropeptide, corticotrophin-releasing
factor (CRF) was shown to have anorexic and orexigenic actions in
the central nervous system. Intracerebroventricular administration
of CRF suppressed food intake (5,6), whereas the CRF receptor
antagonists, a-helical CRF(9–41) and astressin-B, significantly
increased food intake (5) or augmented tail-pinch induced food
intake (7). Conversely, i.c.v. administration of CRF was also shown
to increase food intake, an effect that was blocked by selective CRF
type 1 receptor (CRF-R1) antagonism (4). These results suggest that
CRF is involved in food intake (both hyperphagia and anorexia) in a
stressor-dependent manner. However, the site of action and the
detailed mechanism involved remain to be established.
Animal studies have demonstrated the activation of the
extra-hypothalamic CRF system in modulating food intake (6,8),
specifically during appetitive and aversive events (9). A dense con-
centration of CRF-containing neurones and their receptors lies in
the centromedial nuclear group of the amygdala (10–12). A general
increase in CRF mRNA has been reported as a result of acute and
chronic stress challenges, such as restraint stress or footshock, as
well as corticosterone delivery in the amygdala, specifically in the
central nucleus (CeA) (13). Moreover, microinjection of CRF-R1
antagonist into the CeA completely blocks the excessive intake of
palatable food, as well as anxiety-like behaviour (14), suggesting
that intra-amygdala CRF mediates comfort eating during stress.
Within the amygdala, the highest levels of CRF-R1 expression are
evident in the cortical and medial (MeA) amygdaloid nuclei, with
moderate levels of CRF-R2 expression in the medial amygdala (15).
Lesions of the amygdala have long been known to induce hyper-
phagia and obesity in cats, dogs and monkeys (16). More specifi-
cally, the posterodorsal subnucleus of the medial amygdala (MePD)
has been determined as the effective site in rats, with lesions of
this area disrupting normal feeding behaviour and resulting in
hyperphagia and obesity (16). Activation in the MePD after restraint
stress (17) or exposure to a predator (18) confirms its participation
in psychological stress and is indicative of its functional relation-
ship with anxiety or fear behaviour. However, there is little evidence
for the role of the MePD in modulating stress-induced food intake.
In the present study, we test the hypothesis that the MePD medi-
ates stress-induced food intake involving local CRF signalling. We
investigate whether bilateral neurotoxic lesions of the MePD block
the mild stress of tail-pinch induced food intake in ovariectomised
17b-oestradiol replaced rats. We also investigate whether intra-
MePD administration of CRF per se alters food intake. Finally, we
examine whether tail-pinch induced food intake is blocked by intra-
MePD administration of the CRF-R antagonist, astressin.
Materials and methods
Animals and surgical procedures
Adult female Sprague–Dawley rats (Harlan Laboratories Ltd., Bicester, UK)
weighing 200–250 g were housed individually under a 12 : 12 h light/dark
cycle (lights on 07.00 h) at 22  2 °C and provided with standard rat chow
and water ad lib. All surgical procedures were carried out under ketamine
(100 mg/kg i.p.; Pharmacia and Upjohn, Crawley, UK) and Rompun (10 mg/kg
i.p.; Bayer, Leverkusen, Germany) anaesthesia. Rats were bilaterally ovariec-
tomised and implanted with a Silastic capsule (inner diameter 1.57 mm; outer
diameter 3.18 mm; Sanitech, Havant, UK) filled to a length of 25 mm with
17b-oestradiol (E2) dissolved at a concentration of 20 mg/ml arachis oil
(Sigma-Aldrich, Poole, UK), producing circulating concentration of E2 (approxi-
mately 38  1.2 pg/ml) as described previously (19). All animal procedures
were performed in accordance to the UK Home Office Regulations.
Bilateral lesions of the MePD
Animals received bilateral MePD excitotoxic lesions (n = 12) via bilateral
injections of 0.5 ll of ibotenic acid (10 lg/ll in sterile 0.1 M PBS, pH 7.4;
Sigma-Aldrich) using a 1-ll Hamilton injection syringe connected with a glass
pipette (20) at the coordinates: 3.4 mm lateral, 3.3 mm posterior to bregma
and 8.6 mm below the surface of the dura (21). The sham lesions (n = 8)
were carried out using the same procedure but using sterile 0.1 M sodium
phosphate buffer. MePD lesions were performed at the time of ovariectomy.
Bilateral MePD cannulae implantation
To assess the effect of intra-MePD administration of CRF or CRF-R antago-
nist on food intake and tail-pinch induced food intake, respectively, a sepa-
rate group of rats (n = 35) was implanted with bilateral guide cannulae
(22-gauge; Plastics One Inc., Roanoke, VA, USA) aimed towards the MePD
(coordinates for implantation: 3.3 mm posterior to bregma, 3.4 mm lateral
and 8.6 mm below the surface of the dura) (21). The guide cannula was
anchored to the skull using dental cement (Associated Dental Products Ltd.,
Swindon, UK) (19). The guide cannulae were fitted with dummy cannulae to
prevent obstruction when not in use. All brain cannulae were implanted at
the time of ovariectomy. After surgery, all rats were housed individually and
allowed to recover for 10 days.
Experimental procedures
Effect of MePD lesion on tail-pinch induced food intake
On the morning of experimentation, food was removed 1 h before the tail-
pinch procedure. The animals were then individually moved to a separate
procedure room for the tail-pinch test. Pinch pressure was applied to the
third of the tail extending from the root via a cotton-padded clip for 1 min.
Rats did not vocalise during the application of tail-pinch pressure (1,4).
After the tail clip was removed, the rats were provided with pre-weighted
standard rat chow pellets. Thirty minutes later, the remaining food was
weighed. As a control for tail-pinch, the sham-lesioned rats were monitored
for food intake over a 30-min period, as described above, but in the absence
of tail-pinch. All experiments started between 09.00 and 10.00 h.
Effect of intra-MePD injection of CRF on food intake
Rats were trained prior to the start of the experiment to accustom them to
the intracerebral injection procedure. Twice a day (morning and afternoon) for
3 days, rats were handled by light hand restraint when the dummy cannulae
were removed and reinserted. On the morning of experimentation, rats were
moved to a procedure room and food was removed for 1 h prior to the injec-
tion procedure. Rats were then assigned in a cross-over order to either treat-
ment or control groups. Rats were given a unilateral (right side) intra-MePD
injection of CRF (Sigma-Aldrich) at doses 0.002, 0.02, 0.2 or 2 ng in 300 nl of
artificial cerebrospinal fluid (aCSF) or aCSF as a control (300 nl). An internal
cannula with extension tubing, preloaded with CRF, was inserted into the
guide cannula, extending 1.0 mm beyond the tip to reach the right MePD. The
distal end of the extension tubing was connected to a 2-ll syring (SGE Analyt-
ical Science, Milton Keynes, UK). The extension tubing was held outside the
cage to allow the rat to move freely. The 300 nl of CRF solution or aCSF was
delivered over 2 min and the injection internal cannula was kept in the guide
cannula for another 1 min to prevent backflow. After the injection, pre-
weighted standard chow was placed inside the cage. Food intake over the next
30 min was then measured. Each animal was used up to three occasions with
a different dose on each occasion and a 3-day interval between treatments.
Effect of intra-MePD injection of CRF-R antagonist on tail-
pinch induced food intake
On completion of the CRF treatments described above, the same animals were
used for the CRF antagonist studies after a delay of 5–6 days. A bilateral
intra-MePD injection of astressin (0.3 lg per side dissolved in 300 nl of aCSF;
Sigma-Aldrich) or aCSF (300 nl/side) was administered over 2 min as
described above. Fifteen minutes after injection, the tail-pinch procedure was
carried out as described above. After the tail-pinch, pre-weighted standard
chow was placed inside the cage and food intake over the next 30 min was
measured. Control animals were given bilateral intra-MePD injections of aCSF
or astressin in the absence of tail-pinch. A cross-over design was used for
these experiments with a 3-day interval between treatments. All experiments
started between 09.00 and 10.00 h after a 1-h fast period.
Brain collection and histology verification of lesion site and
cannula position
Animals were killed by decapitation after experimentation. The brains were
removed and snap frozen on dry ice, and then stored at 80 °C and
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coronally sectioned (30 lm) at a later date using a cryostat (Bright lnstru-
ment Co. Luton Ltd, UK). To evaluate the lesion sites, every fourth section
throughout the MePD region corresponding to bregma 2.80 to 3.60 mm
(21) was mounted and stained with cresyl violet. Slides were then viewed
under a light microscope and images were taken using a digital camera
(Zeiss, Oberkochen, Germany) attached to the microscope. Neurones were
identified by appearance and Nissl substance in the cytoplasm. The bound-
aries of the MePD and cannulae placement were determined using neu-
roanatomical landmarks in comparison with the rat brain atlas (21). Animals
with lesion or cannulae outside of the desired structure were excluded from
subsequent analysis.
Statistical analysis
Comparisons between rats that received ibotenic acid and sham lesions, CRF
or CRF antagonist administration and their vehicle controls in the MePD
with respect to food intake were made using ANOVA followed by multiple
comparisons with Dunn’s Test. Data are presented as the mean  SEM and
P < 0.05 was considered statistically statistically significant.
Results
Lesion and cannula position in the MePD
The extent and location of the lesions were confirmed by microscopic
histological inspection, using cresyl-violet staining. The presence of
extensive neurone loss within the MePD was used as a parameter to
determine the existence of significant lesions. Only bilateral lesions
that destroyed the MePD at the same time as leaving the surround-
ing brain tissue largely intact were included in the present study
(Fig. 1A–D). Animals were excluded from the analysis as a result of
unsuccessful lesioning, unilateral damage or damage extending out-
side of the MePD. Of the 12 rats that underwent neurotoxic lesion-
ing, nine were confirmed with correct bilateral lesions in the MePD
and included in the analysis. The remaining three rats with lesions
outside of the MePD were excluded in the analysis. All vehicle-

















Fig. 1. Coronal sections through the rat brain at the level of the posterodorsal medial amygdala (MePD) showing its spatial relation with the surrounding
nuclei and ibotenate lesion, resulting in specific neuronal cell loss. (A) Section without staining showing the lesion in the MePD. (B) Schematic representation
of site of lesion adapted from the rat brain atlas of Paxinos and Watson (21). Representative examples of a lesioned (C, D) and sham-lesioned MePD (E, F),
respectively. Opt, optic tract.
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Out of 35 rats, 29 rats with correct intra-MePD placement of
cannulae were confirmed by histological analysis with reference to
the atlas of Paxinos and Watson (21) and included in the analysis.
A representative example is shown in Fig. 2.
Effect of MePD lesion on tail-pinch induced food intake
To determine whether the MePD is involved in stress-induced food
intake, we measured the amount of food intake within a 30-min
period immediately after tail-pinch in female rats with MePD lesion
compared to sham-lesioned controls. The comparison revealed that
rats with MePD lesion had significantly reduced food intake
(mean  SEM: 0.35  0.16 g, n = 9 per group) compared to their
sham-lesioned controls (1.26  0.13 g, n = 8 per group) (P < 0.05)
(Fig. 3). As an additional control, sham-lesioned rats were moni-
tored for food intake in the absence of tail-pinch (0.36  0.24 g,
n = 5) (Fig. 3). There was no significant difference in food intake
after tail-pinch between misplaced lesioned rats (1.23  0.15 g,
n = 3, P > 0.05) and sham-lesioned controls.
Effect of intra-MePD administration of CRF on food intake
To determine whether CRF signalling in the MePD plays a role in
food intake, CRF was micro-infused into this brain area and food
intake measured in the 30 min post-treatment period. Compared
with aCSF infusion (n = 5), unilateral intra-MePD administration of
CRF significantly increased food intake in a dose-dependent manner
(Fig. 4). A significant increase was observed at the dose of
0.002 ng (n = 7), with a maximum at 0.02 ng (n = 6) CRF com-
pared to vehicle-treated controls (P < 0.05) (Fig. 4). At higher doses
of 0.2 ng (n = 8) and 2 ng (n = 6) CRF, food intake decreased
towards control values, resulting in a bell-shaped effect of CRF on
food intake.
Effect of intra-MePD administration of CRF-R antagonist
on tail-pinch induced food intake
As shown in Fig. 5, exposure to 1-min tail-pinch (n = 9) reliably
increased food intake during the 30 min post-stress period
compared to aCSF-treated controls (n = 9, P < 0.05). Tail-pinch
induced food intake was blocked by bilateral injection of the nonse-
lective CRF antagonist astressin into the MePD (n = 9, P < 0.05).
Intra-MePD administration of astressin alone did not affect food
intake (n = 5, P > 0.05).
Discussion
In the present study, we have shown that lesions of the MePD
caused a significant decrease in tail-pinch induced food intake. Addi-
tionally, intra-MePD administration of CRF resulted in a dose-depen-
dent response on food intake; significantly increasing food intake at
lower doses but decreasing this response at higher doses to provide
a bell-shaped dose–response curve. Furthermore, intra-MePD admin-
istration of the nonselective CRF-R antagonist, astressin, significantly







Fig. 2. Schematic illustrations and photomicrograph of the cannulae target sites in the posterodorsal medial amygdala (MePD). (A) Schematic illustration
showing the target site for bilateral cannulation of the MePD at bregma (AP) 3.3 mm, mediolateral (ML)  3.2 mm and dorsoventral (DV) 8.6 mm accord-
ing to the rat brain atlas of Paxinos and Watson (21). Arrows point to the location of the cannulae tips. (B) Photomicrograph of a coronal brain section in a



















Fig. 3. Effect of tail-pinch induced stress on food intake in the posterodor-
sal medial amygdala (MePD) lesioned rats. Significantly reduced food intake
is observed in MePD lesioned rats in comparison to the sham-lesioned ani-
mals in response to tail-pinch. *P < 0.05 versus absence of tail-pinch in
sham-lesioned animals (control) or lesioned rats exposed to tail-pinch.
Results represent the mean  SEM (n = 5–9 per group).
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been identified as a critical subnucleus of the amygdala in the regu-
lation of food intake (22). Previous studies have shown that a sub-
stantial weight gain occurred only when the lesion extended into the
MePD, and even a small lesion of the MePD resulted in hyperphagia
and substantial weight gains (22,23). The present study, however,
reveals the first evidence for the involvement of CRF signalling in
the MePD in stress-induced feeding.
Although the role of the MePD in stress-induced food intake has
not been established, it has previously been shown that lesions of
the MeA dampened stress-induced increases in corticosterone
release after 30 min of exposure to acute restraint stress (24),
resulting in decreased food intake induced by serotonin agonism
(25) and attenuated stress-induced weight gain (24). The MeA
serves as a key output nucleus of the amygdale complex, promoting
HPA axis activation to acute psychogenic stress (26) and projecting
to many brain regions, including the ventromedial nucleus of the
hypothalamus (VMH) (27,28), which is commonly associated with
satiety. Lesions to the MeA result in a decreased number of CRF
fibres in the VMH (29). In light of this, the findings of the present
study suggest that CRF-mediated stress-induced feeding occurs
along the MePD-VMH pathway, although further research would be
necessary to confirm this hypothesis.
Intra-MePD administration of CRF resulted in a bell-shaped
effect on food intake, indicating that CRF has opposing effects
depending on the dose, which is similar to previous studies using
i.c.v. administration (4). In the latter study, CRF significantly
increased food intake within 30 min after i.c.v. injection at doses of
2 and 10 ng but tended to decrease food intake at higher doses of
250 and 1250 ng in rats. Earlier studies demonstrated the anorexic
effects of CRF on feeding behaviour when microgram doses were
injected i.c.v. to fasted rats (30). These observations may be relevant
to humans showing an increase in appetite with increasing stress
but a gradual loss during periods of more severe stress (31), as well
as in animal models using mild tail-pinch stress, which increases
food intake, whereas more severe stress such as restraint and foot-
shock inhibit food intake (4,32). Therefore, a differential role for
endogenous CRF-signalling in stress-induced feeding is implicated;
CRF alters food intake depending on the intensity of stress (i.e. mild
versus severe). The findings of the present study suggest that food
intake therefore may indicate the degree of stress severity.
The amygdala, especially its central nucleus, is a major course of
CRF neuronal perikarya (29,33) with a widespread projection, and is
implicated in behavioural and physiological responses associated
with fear, anxiety, stress, food intake and reward. However, whether
these CRF neurones project to the MePD remains to be established.
Bilateral intra-MePD administration of astressin, a nonselective CRF-
R antagonist, significantly reduced tail-pinch induced food intake.
The orexigenic effect of tail-pinch, as seen in the present study, is a
robust observation (1,4,6,7) and represents a reliable model of stress-
induced hyperphagia that may involve activation of the CRF system
(5). However, previous investigations on the influence of brain CRF
signalling pathway in the tail-pinch feeding response have led to
contradictory results (4,5,7). Treatment with a low dose (1 lg) of the
CRF antagonist (i.c.v.) increased the duration of eating and amount
of food intake during a 5-min tail-pinch session (5,7). However, i.c.v.
administration of higher doses of a-helical CRF(9–41) (5 and 25 lg),
or a selective type 1 CRF-R antagonist, CRA 1000, reduced or blocked
tail-pinch induced food intake (4). These discrepancies could be
explained by differences in the experimental setting, such as rats
being exposed to tail-pinch for 5 min versus 1 min, feeding beha-
viour being evaluated only during the 5-min tail-pinch period instead


















Fig. 5. Effect of bilateral intra-posterodorsal medial amygdala (MePD)
microinjection of corticotrophin releasing factor receptor (CRF-R) antagonist
on tail-pinch induced food intake. Acute 1-min tail-pinch significantly
induced food intake that was blocked by microinjection of the nonselective
CRF-R antagonist, astressin, at a dose of 0.3 lg per side in 300 nl of artifi-
cial cerebrospinal fluid (aCSF) (n = 9 per group). Intra-MePD administration
of aCSF (n = 9) or astressin (n = 5) alone did not affect food intake.

















aCSF 0.002 0.02 0.2 2
Fig. 4. Effect of intra-posterodorsal medial amygdala (MePD) microinjection
of corticotrophin-releasing factor (CRF) on food intake. A significant dose-
dependent increase in food intake at 30 min was observed at doses of
0.002 and 0.02 ng CRF in 300 nl of artificial cerebrospinal fluid (aCSF).
However, food intake decreased at further higher doses providing a bell-
shaped dose response. *P < 0.05 versus controls. Results represent the
mean  SEM (n = 5–8 per group).
© 2016 The Authors. Journal of Neuroendocrinology published by John Wiley & Sons Ltd
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used. Moreover, different CRF-R antagonists, such as a-helical
CRF(9–41) and astressin-B (i.e. a nonselective CRF-R antagonist versus
a selective CRF-R1 antagonist), have been used in these studies. Both
CRF-R1 and -R2 are involved in the inhibition of food intake (34–
36), whereas knockout of type 2 CRF-R causes a ‘pro-satiation’ effect
after acute restraint stress (36). However, a differential role for either
receptor subtype in food regulation remains uncertain. Within the
amygdala, the highest levels of CRF-R1 mRNA expression were evi-
dent in the medial nucleus, although moderate levels of CRF-R2
were also detected in this same subnucleus (15). Because tail-pinch
induced food intake was blocked by intra-MePD administration of
astressin in the present study, as well as by i.c.v. administration of
the CRF-R1 selective antagonist (4), it would appear that tail-pinch
induced food intake behaviour may be mediated through CRF-R1 in
the MePD. However, further investigations into a possible differential
role of type 1 and type 2 CRF-R in MePD-mediated food intake are
needed.
In humans, comfort eating is characterised by ‘eating to feel
better’, inferring that eating goes beyond the realm of meeting
metabolic and energy needs alone, which begs the question of its
evolutionary significance. Stimulation of reward pathways in the
limbic system has been found, likely contributing to the elevation in
mood after eating under stressful conditions (37). Studies in
rodents have demonstrated attenuated stress responses (i.e. damp-
ened HPA axis activation) to chronic restraint stress when given
lard or sucrose compared to rodents given no food (38). This might
suggest that comfort eating is a source of ‘self-medication’ for the
regulation of stress responses (39). However, although the tail-
pinch procedure readily increases feeding in this rodent model of
acute mild stress, increased feeding in humans is generally associ-
ated with chronic stress and therefore a note of caution regarding
any clear translational link is warranted.
Collectively, these findings provide new evidence for a role of
medial amygdaloid CRF mediating stress-induced feeding. This
potentially provides a target brain area for treatment of obesity
and related stress conditions.
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